Whitehawk Therapeutics Inc (WHWK)
Whitehawk Therapeutics Inc operates in the Biotechnology industry of the Healthcare sector, headquartered in Morristown, NJ, US. The stock last traded at $3.74, down 3.11% on the session, giving a market capitalisation of $213.2M. On trailing twelve-month figures it carries a trailing P/E of -3.34, a net margin of 0.0%. Its beta of 0.81 implies it has historically moved less than the broad market.
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
Whitehawk Therapeutics Inc is most often compared with the following Healthcare names: